| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $86.3M | $79.7M | $90.6M |
| YoY Revenue Growth % | +8.3% | -12.0% | — |
| Gross Profit | $28.1M | $20.2M | — |
| Gross Margin % | 32.6% | 25.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.6M | -$10.6M | -$10.8M |
| Operating Margin % | -1.9% | -13.3% | -11.9% |
| Net Income (GAAP) | -$3.2M | -$13.6M | -$15.7M |
| EBITDA (Normalized) | -$1.6M | -$10.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.1M | $599.0K | -$10.1M |
| Capital Expenditures (CapEx) | $83.0K | $99.0K | — |
| Free Cash Flow (FCF) | -$1.2M | $500.0K | -$10.1M |
| FCF Margin % | -1.3% | 0.6% | -11.1% |
| Return on Invested Capital (ROIC %) | -8.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $4.7M | $7.5M | — |
| Total Debt (Short + Long Term) | $9.0M | — | — |
| Total Stockholders' Equity | $11.8M | $14.5M | — |